Next steps in VTE treatment: will oral edoxoban replace the current standard of care?
Using vaccines to impart a long-term response in lenalidomide-treated MM
Ivan Marques Borrello
The standardization of molecular diagnostics for myeloid diseases in Italy
Exploiting signalling pathways involved in CLL to develop novel therapies
Using validated next-generation techniques for monitoring MRD in multiple myeloma